bs-82532C
[Life Science]
Montelukast sodium
DATASHEET
Formulation Olive green solid
Storage: -20°C
Product Information:
Potent, selective CysLT1 receptor (leukotriene D4) antagonist (Ki = 0.18 nM).1,2 Displays anti-inflammatory and anti-asthmatic effects. Clinically useful agent for treatment of chronic asthma.3 Attenuates chronic brain injury after focal cerebral ischemia in rodent models.4 Decreases blood brain barrier dysfunction in mouse models.5 Blockade of GPR17 by montelukast elevates neural stem and progenitor proliferation.6
Description:
CAS Number: 151767-02-1<br></br>Chemical Name: 2-[1-[[(1R)-1-[3-[(E)-2-(7-Chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetate, sodium salt<br></br>Molecular weight: 608.17<br></br>Formula: C35H35ClNO3S Na <br></br>Solubility: DMSO (60 mg/ml) Water (30 mg/ml) Ethanol (60 mg/ml)<br></br>Physical Properties: Solid<br></br>Purity: 98% by HPLC, NMR (Conforms)
Size: 50 mg, 250 mg50 mg, 250 mg
Applications: Life Science()
For research use only. Not intended for diagnostic or therapeutic use.